Newsletters
January 17, 2024
January 2024 Newsletter
More News
& publications
PQE Group Announces Release of 2025 Sustainability Report
PQE Group is pleased to announce it has completed and released its 2025 Sustainability Report…
Québec is the first province to list PrOKEDIMC on the public drug reimbursement formulary for the treatment of schizophrenia
Bausch Health, Canada Inc., a subsidiary of Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), announces the listing…
Pitch your next-generation immunotherapy innovation to experts from leading global pharmaceutical companies on September 16, 2026!
We are seeking ambitious next-generation immunotherapy innovations with strong…
